Cameron Best

Dr. Best hails from rural Maine and graduated from Yale University as a member of the Lightweight Crew (Y150) with a BA in Linguistics. During this time, he volunteered in the laboratory of Drs. Christopher Breuer and Toshiharu Shinoka (Vascular Biology and Therapeutics Program) where he dedicated his efforts to the development of a tissue-engineered vascular graft. He followed the laboratory to Nationwide Children's Hospital in Columbus, OH to support an FDA-approved clinical trial evaluating the graft as a Fontan conduit in patients with congenital heart disease. He earned a PhD in Biomedical Science from the Ohio State University and co-founded Lyst Therapeutics, LLC which developed novel immunomodulatory therapies to facilitate tissue engineering in the pediatric population. He then graduated from the Ohio State University College of Medicine. He is honored to return to Yale as a member of the Integrated Cardiothoracic Residency Program and aims toward a career as a surgeon-scientist, continuing the translation of tissue-engineered solutions to the field of congenital heart surgery.